Rikhi, Rishi http://orcid.org/0000-0002-8013-4564
Shapiro, Michael D. http://orcid.org/0000-0002-9071-3287
Funding for this research was provided by:
Wake Forest University
Article History
Accepted: 16 September 2024
First Online: 20 September 2024
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Michael D. Shapiro is supported by institutional grants from Amgen, Arrowhead, Boehringer Ingelheim, 89Bio, Esperion, Novartis, Ionis, Merck, and New Amsterdam; and he has participated in Scientific Advisory Boards with Amgen, Agepha, Ionis, Novartis, New Amsterdam, and Merck. He has also served as a consultant for Ionis, Novartis, Regeneron, Aidoc, Shanghai Pharma Biotherapeutics, Kaneka, Novo Nordisk, Arrowhead, and Tourmaline. Rishi Rikhi has nothing to disclose.